A22G (p.Ala22Gly) variant of MFN2 (Mitofusin-2)
A22G (p.Ala22Gly) in MFN2 (Mitofusin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
A22G (p.Ala22Gly) variant details
- p.Ala22Gly
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available